title: The vasoactive-inotropic score and levosimendan: time for LVIS?
authors.forename: Isabella
authors.initials: I
authors.lastname: Favia
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Vitale
authors.forename: Zaccaria
authors.initials: Z
authors.lastname: Ricci
mesh_terms: D006348:Cardiac Surgical Procedures / Q000379:methods; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D004359:Drug Therapy, Combination; D006330:Heart Defects, Congenital / Q000601:surgery; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000627:therapeutic use*; D009200:Myocardial Contraction / Q000187:drug effects*; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D000077464:Simendan; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D014665:Vasodilator Agents; D000077464:Simendan